Vanda Pharmaceuticals Inc (VNDA)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD

VNDA Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
VNDA Quarterly Deferred Revenue ($129.95K → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
VNDA deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -2,308,000 | |
| -1,735,000 | |
| -1,953,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 174,000 | |
| 31,232,000 | |
| 31,059,000 | |
| 31,059,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 27,242,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,789,000 | |
| 26,788,991 | |
| 26,788,991 | |
| 26,788,991 | |
| 26,788,991 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 141,229,000 | |
| 142,411,000 | |
| 129,950,000 | |
| 136,251,000 | |
| 136,501 | |
| 133,738 | |
| 129,950 |